Skip to main content

Advertisement

SpringerLink
Log in

Presentation and Management of Inguinal Lymphadenopathy in Ovarian Cancer

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

The symptoms in ovarian cancer are often missed leading to dubious diagnosis and staging. Inguinal lymphadenopathy (ILAP) is reported to be rare and occurring via lymphatic or hematogenous route. The paucity of studies on ILAP in ovarian cancer indicates a scope of refining its staging and management. The present study aims to document the presentation and management of ILAP in ovarian cancer, which may also reflect its incidence and mechanism of spread. All patients of ovarian cancer with inguinal lymphadenopathy presenting to our institute from 1 January 2015 to 31 December 2015 were included. All clinical, treatment, and pathological details were analyzed. Seven patients of ovarian cancer presented with ILAP. The mean age and BMI were 53.29 +/− 8.38 years and 26.23 +/− 3.03 kg/m2. Presentation varied from advanced disease (adnexal, omental, peritoneal, and nodal) to isolated ILAP even without adnexal mass (n = 4). Mean CA 125 was 229.64 +/− 322 (20–924) and ovarian primary was confirmed on microscopy or immunohistochemistry. Six patients underwent surgery with (n = 4) or without neoadjuvant chemotherapy (n = 2). Complete cytoreduction could be achieved in all patients with acceptable operative and perioperative outcomes. Peritoneal surface spread, along hernia track to the groin, was seen in two patients. Histopathology showed advanced disease, isolated ILAP and no residual disease in 3, 2, and 1 patient, respectively. ILAP has diverse clinical presentation in ovarian cancers and is not that uncommon. ILAP may also occur by peritoneal surface spread and shows good results with cytoreductive surgery and chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Di Giorgio A, Naticchioni E, Biacchi D, et al. (2008) Cytoreductive surgery (peritonectomy procedures) combined with HIPEC in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 113:315–325

    Article  PubMed  Google Scholar 

  2. Dvoretsky PM, Richards KA, Angel C, Rabinowitz L, Stoler MH, Beecham JB, Bonfiglio TA (1988) Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 19(1):57–63

    Article  CAS  PubMed  Google Scholar 

  3. Ferrero A, Ditto A, Giorda G, et al. (2014) Secondary cytoreductive surgery for isolated lymph node recurrence of epitheliovarian cancer: a multicenter study. Eur J Surg Oncol 40(7):891–898

    Article  CAS  PubMed  Google Scholar 

  4. Yang XJ, Zheng FY, Xu YS, Ou RY (2014) Ovarian cancer initially presenting with isolated ipsilateral superficial inguinal lymph node metastasis: a case study and review of the literature. J Ovarian Res 7(1):1

    Article  Google Scholar 

  5. Ang D, Ng K, Tan H, Chung AY, Yew B, Lee VK (2007) Ovarian carcinoma presenting with isolated contralateral inguinal lymph node metastasis: a case report. Ann Acad Med Singap 36(6):427

    PubMed  Google Scholar 

  6. Rose PG, Piver MS, Tsukada Y, Lau T (1989) Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer 64(7):1508–1513

    Article  CAS  PubMed  Google Scholar 

  7. Eichner E, Bove ER (1954) In vivo studies on the lymphatic drainage of the human ovary. Obstet Gynecol 3(3):287–297

    CAS  PubMed  Google Scholar 

  8. Fotiou S, Aliki T, Petros Z, Ioanna S, Konstantinos V, Vasiliki M, George C (2009) Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer. Gynecol Oncol 114(2):178–182

    Article  PubMed  Google Scholar 

  9. Scholz HS, Lax S, Tamussino KF, Petru E (1999) Inguinal lymph node metastasis as the only manifestation of lymphatic spread in ovarian cancer: a case report. Gynecol Oncol 75(3):517–518

    Article  CAS  PubMed  Google Scholar 

  10. Kehoe S, Luesley D, Rollason T (1993) Ovarian carcinoma presenting with inguinal metastatic lymphadenopathy 33 months prior to intraabdominal disease. Gynecol Oncol 50(1):128–130

    Article  CAS  PubMed  Google Scholar 

  11. Loredo DS, Powell JL, Reed WP, Rosenbaum JM (1990) Ovarian carcinoma metastatic to breast: a case report and review of the literature. Gynecol Oncol 37(3):432–436

    Article  CAS  PubMed  Google Scholar 

  12. Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Meyers CE (1985) Prospective randomized trial of intravenous vs intraperitoneal 5—Fuin patients with advanced primary colon or rectal cancer. SeminOncol 12:101–111

    CAS  Google Scholar 

  13. Ferrandina G, Legge F, Petrillo M, Salutari V, Scambia G (2007) Ovarian cancer patients with “node-positive-only” stage IIIC disease have a more favorable outcome than stage IIIA/B. Gynecol Oncol 107(1):154–156

    Article  CAS  PubMed  Google Scholar 

  14. Blanchard P, Plantade A, Pagès C, Afchain P, Louvet C, Tournigand C, de Gramont A (2007) Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors. Gynecol Oncol 104(1):41–45

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, New Delhi, 110085, India

    Shveta Giri, Swati H Shah, Kanika Batra,  Anu-Bajracharya, Vandana Jain, Himanshu Shukla, Rupinder Sekhon & Sudhir Rawal

Authors
  1. Shveta Giri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Swati H Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kanika Batra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anu-Bajracharya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vandana Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Himanshu Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rupinder Sekhon
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sudhir Rawal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shveta Giri.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

The authors have strictly adhered to the ethical norms.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giri, S., Shah, S.H., Batra, K. et al. Presentation and Management of Inguinal Lymphadenopathy in Ovarian Cancer. Indian J Surg Oncol 7, 436–440 (2016). https://doi.org/10.1007/s13193-016-0556-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0556-7

Keywords

Search

Navigation